SWK (NASDAQ:SWKH) Stock Price Down 1.6% - Time to Sell?

Key Points

• SWK Holdings Corp. shares fell 1.6%, trading at $14.47 after a previous close of $14.70 with a slightly lower trading volume.
• Analysts have recently adjusted their ratings on SWK, with Wall Street Zen downgrading the stock to a "hold" and Maxim Group lowering the price target from $21.00 to $18.00.
• SWK reported $0.38 earnings per share, exceeding analyst estimates of $0.18, alongside a notable 39% net margin for the quarter.

SWK Holdings Corp. (NASDAQ:SWKH - Get Free Report) shares were down 1.6% during trading on Monday . The company traded as low as $14.46 and last traded at $14.47. Approximately 13,238 shares changed hands during trading, a decline of 2% from the average daily volume of 13,537 shares. The stock had previously closed at $14.70.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Maxim Group cut their price objective on shares of SWK from $21.00 to $18.00 and set a "buy" rating on the stock in a research report on Monday, May 19th. Wall Street Zen cut shares of SWK from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, SWK currently has an average rating of "Buy" and a consensus target price of $18.00.

SWK Stock Up 0.5%

The company has a debt-to-equity ratio of 0.13, a quick ratio of 3.17 and a current ratio of 3.17. The company has a market cap of $181.16 million, a price-to-earnings ratio of 10.50 and a beta of 0.16. The stock's fifty day moving average is $14.86 and its two-hundred day moving average is $15.45.

SWK (NASDAQ:SWKH - Get Free Report) last posted its earnings results on Thursday, August 14th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.20. SWK had a net margin of 39.00% and a return on equity of 8.43%. The company had revenue of $10.05 million for the quarter.

Institutional Investors Weigh In On SWK

Institutional investors and hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC raised its holdings in shares of SWK by 2,955.0% in the 1st quarter. GAMMA Investing LLC now owns 3,391 shares of the company's stock worth $59,000 after acquiring an additional 3,280 shares during the last quarter. Russell Investments Group Ltd. raised its holdings in shares of SWK by 139.0% in the 1st quarter. Russell Investments Group Ltd. now owns 4,065 shares of the company's stock worth $71,000 after acquiring an additional 2,364 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of SWK by 41.8% in the 2nd quarter. Bank of America Corp DE now owns 5,595 shares of the company's stock worth $82,000 after acquiring an additional 1,649 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of SWK by 13.3% in the 1st quarter. Rhumbline Advisers now owns 5,690 shares of the company's stock worth $99,000 after acquiring an additional 666 shares during the last quarter. Finally, State of Wyoming increased its stake in SWK by 42.5% in the 4th quarter. State of Wyoming now owns 7,374 shares of the company's stock valued at $117,000 after buying an additional 2,200 shares during the last quarter. Institutional investors and hedge funds own 99.27% of the company's stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.